The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis
 
Jiri Mayer
Research Funding - Merck
 
Ohad Benjamini
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
 
Alejandro Berkovits
Speakers' Bureau - Pfizer
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Janssen (Inst)
 
Ingrid Glimelius
Other Relationship - Janssen-Cilag; Takeda (Inst)
 
Don A. Stevens
No Relationships to Disclose
 
Arvind Chaudhry
Employment - American Oncology Network
 
Ahmet Muzaffer Demir
No Relationships to Disclose
 
Ramón Garcia Sanz
Honoraria - Amgen; AstraZeneca Spain; Beigene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Janssen
Research Funding - Astellas Pharma; Incyte (Inst); Takeda (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - BIOMED 2 primers (Inst)
Travel, Accommodations, Expenses - Janssen; Takeda (I)
Other Relationship - Spanish Society of Hematology
 
Won Seog Kim
Research Funding - BeiGene; Boryung; Dong-A Socio; Kyowa Kirin; Roche; Sanofi
 
Fei Li
No Relationships to Disclose
 
Janusz Halka
No Relationships to Disclose
 
Ana Marin-Niebla
Honoraria - AstraZeneca; Janssen; Kite, a Gilead Company; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen; Kite, a Gilead Company
Travel, Accommodations, Expenses - Janssen; Kite, a Gilead Company; Takeda
 
Muhit Ozcan
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Bayer; Dr. Reddy's Laboratories; Janssen; Merck; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Jazz Pharmaceuticals; Roche
 
Ewa Paszkiewicz-Kozik
Consulting or Advisory Role - Takeda
Speakers' Bureau - Abbvie; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Incyte; MSD; Pfizer; Sanofi; SERVIER
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Bayer; BMS; Celgene; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Sandoz; Servier; Takeda
 
Yixin Ren
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Uzor Ogbu
Employment - Merck
Stock and Other Ownership Interests - Merck; Roche
 
Patricia Marinello
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Roche
Research Funding - Acerta Pharma; BeiGene; Epizyme; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics